ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
25 hedge funds and large institutions have $7.64M invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2014 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 4 closing their positions.
10% more capital invested
Capital invested by funds: $6.97M → $7.64M (+$672K)
0% more funds holding
Funds holding: 25 → 25 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Platinum Management
New York
|
+$1.55M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$1.33M |
| 3 |
Jane Street
New York
|
+$61.5K |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$15.6K |
| 5 |
Citigroup
New York
|
+$1.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$122K |
| 2 |
EEG
E.E. Geduld
|
-$62.1K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$36K |
| 4 |
Barclays
London,
United Kingdom
|
-$30K |
| 5 |
EWM
Edge Wealth Management
New York
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$10 | -4 | -17% |
|
27
Ameriprise
Minneapolis,
Minnesota
| – | +$497 | +200 | New |
|
ECTE Hedge Fund Activity: Q2 2014 in Review
25 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q2 2014, worth a combined $7.64M — up 9.6% from $6.97M a quarter earlier.
Fund positioning in ECTE was balanced in Q2 2014: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 8 trimmed.
The largest buyer was Platinum Management, adding an estimated $1.55M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $122K sold.
- 25 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $7.64M of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q2 2014, up 9.6% quarter-over-quarter.
- 4 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q2 2014 and 4 closed out, a net change of 0 holders.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q2 2014 was Platinum Management, an estimated $1.55M added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q2 2014 was Renaissance Technologies, an estimated $122K sold.
Based on aggregated 13F filings for Q2 2014.